Thank you for visiting Pot Valet. We are the most reliable online marijuana retail store in California. To recreational users of marijuana, we deliver high-quality, laboratory tested products. Our team is in partnership with the best marijuana dispensaries in the state, and our goal is to ensure that pot delivery to all parts of California is safe, fast, and always available.
In an article by the Madera Tribune, it stated that Madera growers will need to obtain a permit from the city which will need to be displayed in plain view at the residence where the growing will occur. Failure to do so could result in a $1,000 fine per plant or possibly, per day. Renters who would like to grow in their residence would need written permission from their landlord before applying for a permit with the city.
“When we had conversations with physicians about the data, some would say, ‘My patient is sicker than yours,’ or ‘I have a different patient population.’ However, we can drill down to the physician’s patients and show the physician where things are. It’s not based on an ivory tower analysis, it’s based on our own data. And, yes, our patients, and our community, are unique—a little older than most, and we have a lot of Europeans here visiting. We have some challenges, but this tool is taking our data and showing us what we need to pursue. That’s pretty powerful.”
It was the year 2000 and I left Abott’s Habit. A friend of mine was moving out of town and all his friends needed weed, so that’s how I started my delivery service. It was just me with a pager, seven days a week. I couldn’t keep up with all the orders. My team grew to four girls and we split profits evenly. It became more like a private club, with a password to access. Eventually a woman I had a catering company with got upset and reported me to Santa Monica Police. They came in, raided us and took everything. I went to court and had to go through the legal system. Today I have an amazing lawyer who helped us file for a delivery license in California so we can transition to the recreational market.
“That was a major effort, but some of us had been data scientists before we were physicians, and so we parameterized all these calls. The first pneumonia care path was completed in about nine weeks. We’ve turned around and did a second care path, for sepsis, which is much harder, and we’ve done that in two weeks. We’ve finished sepsis and have moved on to total hip and total knee replacements. We have about 18 or 19 care paths that we’re going to be doing over the next 18 months,” he says.
After being fed data of past pneumonia treatments, the software automatically created cohorts of patients who had similar outcomes accompanied by the treatments they received at particular times and in what sequence. The program also calculated the direct variable costs, average lengths of stay, readmission and mortality rates for each of those cohorts, along with the statistical significance of its conclusions. Each group had different comorbidities, such as diabetes, COPD and heart failure, which was factored into the application's calculations. At the push of a button, the application created a care path based on the treatment given to the patients in each cohort.
The hospital quickly implemented the new pneumonia pathway by changing the order set in its Allscripts EHR system. As a result, for the pneumonia care path, Flagler Hospital saved $1,350 per patient and reduced the length of stay (LOS) for these patients by two days, on average. What’s more, the hospital reduced readmission by 7 times—the readmission rate dropped from 2.9 percent to 0.4 percent, hospital officials report. The initial work saved nearly $850,000 in unnecessary costs—the costs were trimmed by eliminating labs, X-rays and other processes that did not add value or resulted in a reduction in the lengths of stay or readmissions.
Salt Lake City, Utah-based patient management platform maker Collective Medical Technologies announced today that it has raised $47.5 million in a series A funding round led by investment firm Kleiner Perkins. Other participants in the round include Bessemer Venture Partners, Maverick Ventures, Kaiser Permanente Ventures, Providence Ventures, Peterson Ventures, and Epic Ventures.